Skip to main content

MCTA · Charming Medical Ltd

Track MCTA — free
$29.36 +1.86 (+6.75%) At close · Nov 11
Market Cap
$445.55M
Shares
15.18M
Volume · Nov 11 4.25M Avg daily vol (16 sessions) 874.42K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$29.36 Open$28.35 Day$25.90–31.70 Available close range$6.20–29.36 Avg vol available · 16d874K Short int575K · 3.8% float Short vol47% DataOct 2025–Nov 2025

The closing range uses available history since Oct 21, 2025; less than a full year is stored.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-22.7%
Year over year
Operating margin
-0.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+5.3%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
3.8%
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Limited Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 19 · elevated Equity put/call 0.69
Technical
price trend
Neutral
50 / 200-day cross No cross
RSI (14) 79
overbought
52-week position 100%
near high
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.79% of float · ▼ -0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3 holders — 13F breadth
Squeeze score 53
elevated · 0–100
Fundamentals
Weak
Revenue growth −23%
Y/Y
EPS growth −100%
Y/Y
Free cash flow $-1.6M
Balance sheet $4.3M
net cash
Quant / Vol
risk profile
Very High
Volatility 320%
annualized · 1-yr
Max drawdown −26%
past year
ATR 14.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 1 · 1
50 / 200-day cross
No cross Neutral
RSI (14)
79 Bearish
52-week position
100% Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.79% of float · ▼ -0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3 holders — 13F breadth
Price context
position in its available closing range
Range low $6 Now $29 · 100% Range high $29

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MCTA
Charming Medical Ltd
this stock
$445.55M — -22.7% — 3.8%
HCA
HCA Healthcare, Inc.
$103.67B +0.1% +7.1% 15.7 2.2%
FSNUY
Fresenius SE & Co. KGaA
$28.77B -10.9% — — 0.0%
THC
Tenet Healthcare Corp
$21.79B +36.2% +0.9% 10.4 2.3%
EHC
Encompass Health Corp
$12.43B +18.7% +10.5% 20.5 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
3
% held
0.3%
Net QoQ
-700 sh
Top holder
UBS Group AG
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
574.5K
Days to cover
1000.0d
Change
-260 sh
View
Short Volume
Short vol %
47%
As of
Nov 11, 2025
Short Total
View
Fails to Deliver
FTD shares
160
Value
$4.7K
As of
Sep 17, 2026
View
Off-Exchange
Off-exchange %
25.0%
Week of
Nov 10, 2025
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$4.8M
Net income (FY)
$-22.6K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 29, 2026
This year
8
View

Performance

5D 20D 120D MTD YTD
MCTA +33.3% — — +24.9% —
SPY +1.2% +3.1% +17.2% +0.1% +16.5%
vs SPY +32.2% — — +24.8% —
Key facts CIK 2035992 CUSIP G20528108 Visit website